Clinical Trial Update: Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY] [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating blood tumor mutational burden (TMB) as a biomarker for the efficacy of atezolizumab in malignant lung neoplasms has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lung Malignant Neoplasm
• Lung Neoplasm

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Lung Neoplasm Malignant | Phase 4 | Status: COMPLETED